The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...
IV therapy has been used for decades in hospitals to treat a range of conditions, from dehydration to nutrient-absorption disorders, but it’s increasingly offered at independent clinics and ...
The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...
In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard ...
A new study shed light on the large proportion of nursing home residents who have venous catheters, or intravenous (IV) lines ...
Prince Karim Al-Hussaini, the Aga Khan IV and 49th hereditary imam of the Shiite Ismaili Muslims, died at his home in Lisbon, Portugal on Tuesday. He was 88 years old. The Aga Khan IV can trace ...
By Alan Cowell The Aga Khan IV, who as the leader of the world’s Ismaili Muslims fused entrepreneurship and philanthropy in becoming one of the world’s wealthiest hereditary rulers ...
Born on Oct. 12, 1971, the U.S.-educated, Swiss-based Rahim is the eldest son of the Aga Khan IV and his first wife, Princess Salimah - née Sarah Croker Poole, a British ex-model. The couple had ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...
The Aga Khan IV, a revered spiritual leader, philanthropist, and one of the world's wealthiest men, passed away at the age of 88 in Lisbon, Portugal. As the 49th hereditary Imam of the Shia ...
About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback